Weight Watchers International Inc is a global leader in weight management and wellness solutions, empowering individuals to achieve sustainable health through personalized plans, community support, and comprehensive resources. The company utilizes a holistic approach to weight loss that encompasses not only dietary guidance but also lifestyle changes, physical activity, and mental well-being. By combining innovative technology with a strong community aspect, Weight Watchers offers its members a flexible and adaptable program designed to fit their individual needs and preferences, fostering long-term success and healthier living. Read More
Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 10.6% in the morning session after the company reported third-quarter 2025 financial results that surpassed revenue and adjusted profit expectations, despite a significant miss on bottom-line earnings.
Personal wellness company WeightWatchers (NASDAQ:WW) announced better-than-expected revenue in Q3 CY2025, but sales fell by 10.8% year on year to $172.1 million. The company’s full-year revenue guidance of $697.5 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP loss of $5.76 per share was significantly below analysts’ consensus estimates.
A number of stocks fell in the morning session after markets became increasingly wary of high valuations following a significant AI-driven rally. The tech-heavy Nasdaq fell approximately 1.4% as a wave of caution swept through the market.
Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of renewed discussions with Novo Nordisk A/S (NYSE: NVO) regarding the potential distribution of Wegovy. While the telehealth platform reported a
Most consumer discretionary businesses succeed or fail based on the broader economy. Lately, it seems like demand trends have worked in their favor as the industry has returned 25% over the past six months,
similar to the S&P 500.
A number of stocks jumped in the afternoon session after a cooler-than-expected inflation report fueled optimism for potential Federal Reserve rate cuts. The September Consumer Price Index (CPI) rose 3.0% year-over-year, coming in just below the 3.1% analysts had forecast. While still above the Federal Reserve's 2% target, investors interpreted the slight cooling as a sign that inflationary pressures may be easing, potentially giving the central bank room to consider interest rate cuts in the near future. Sectors that are typically sensitive to interest rates, such as real estate and utilities, saw a notable lift. Lower rates can reduce borrowing costs and increase the appeal of dividend-paying stocks, boosting investor confidence in these areas.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 9.6% in the afternoon session after it announced a partnership with Amazon Pharmacy for faster home delivery of its weight-loss medications.
A number of stocks fell in the afternoon session after a confluence of negative economic data pointed to a weak economy. The latest Survey of Consumer Expectations from the New York Fed revealed that households' short-term inflation expectations rose, while their outlook on the labor market deteriorated. Consumers expressed greater concern about potential job losses and expected lower earnings growth, factors that directly impact discretionary spending.
Adding to the unease, Chief Economist at Moody’s Analytics, Mark Zandi, warned that 22 states demonstrated clear signs of a recession, placing the broader U.S. economy in a precarious position. The U.S. government shutdown further dampened sentiment, threatening to weigh on incomes and purchasing power.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at specialized consumer services stocks, starting with WeightWatchers (NASDAQ:WW).
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the specialized consumer services industry, including WeightWatchers (NASDAQ:WW) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Matthews (NASDAQ:MATW) and the rest of the specialized consumer services stocks fared in Q2.
Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 3% in the afternoon session after CJS Securities initiated coverage on the company, bringing fresh eyes to the wellness brand.
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is fundamentally altering the landscape of medical treatment and diagnostics, promising a future of more personalized, precise, and preventive medicine. At the forefront of this
A number of stocks jumped in the afternoon session after the latest Consumer Price Index (CPI) report came in largely as expected, reinforcing investor hopes for an upcoming Federal Reserve interest rate cut.
Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 8.3% in the morning session after it continued a rally from the previous session after the company announced a new comprehensive program called WeightWatchers for Menopause. The stock gained over 5% on Monday following the initial announcement and is extending those gains today. The new program is designed to provide a holistic approach to weight management and symptom relief for women experiencing menopause. It will offer members access to clinicians trained in menopause care who can provide individualized plans. Importantly, these plans may include prescription options such as hormone replacement therapy or popular GLP-1 medications when deemed appropriate. The company also revealed that Queen Latifah will be the official spokeswoman for the new initiative, adding celebrity endorsement to the launch.
